Evidence map›Paper›PMID 42852083›Full record

ReviewFrontiers in microbiology2026

Host miRNA orchestration of mitophagy pathways during bacterial infection: current advances and future directions.

Xin Hu, Wei Jiang, Xiangting Yuan, Qinqin Pu, Kelei Zhao, Ting Huang

Abstract readReview
In one paragraph

Review in Frontiers in microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Xin Hu *Clinical Medical College and Affiliated Hospital of Chengdu University, Chengdu University, Chengdu, China.
Wei Jiang *Antibiotics Innovation and Resistance Control Key Laboratory of Sichuan Province, School of Pharmacy, Chengdu University, Chengdu, China.
Xiangting YuanAntibiotics Innovation and Resistance Control Key Laboratory of Sichuan Province, School of Pharmacy, Chengdu University, Chengdu, China.
Qinqin PuDepartment of Microbiology, University of Pennsylvania, Philadelphia, PA, United States.
Kelei ZhaoAntibiotics Innovation and Resistance Control Key Laboratory of Sichuan Province, School of Pharmacy, Chengdu University, Chengdu, China.
Ting HuangAntibiotics Innovation and Resistance Control Key Laboratory of Sichuan Province, School of Pharmacy, Chengdu University, Chengdu, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pathogenic bacterial infections continue to impose a substantial global health burden. MicroRNAs (miRNAs), a class of small non-coding RNAs, have emerged as critical post-transcriptional regulators of host innate immunity and inflammatory responses during bacterial pathogenesis. Accumulating evidence indicates that miRNAs dictate the outcomes of infection by orchestrating fundamental cellular processes, notably mitophagy-a selective autophagic pathway essential for mitochondrial quality control and cytosolic surveillance. While recent studies have begun to elucidate the molecular interplay between miRNA biogenesis and mitophagy regulation, the mechanistic crosstalk between miRNAs and mitophagy during bacterial infection remains fragmentary, and many reported miRNA-mitophagy regulatory relationships are derived from non-infectious disease models rather than bacterial infection settings. In this review, we synthesize current advances regarding miRNA-mediated modulation of core mitophagy machinery and associated signaling cascades in the context of bacterial infection. We further explore the pathophysiological implications of these regulatory networks and evaluate the therapeutic potential of targeting specific miRNA-mitophagy axes. This study provides mechanistic insights into how host miRNAs reprogram mitophagy to combat infection and the miRNA-mitophagy axis maybe as a promising dual-targeted therapeutic strategy for the development of host-directed therapies against bacterial diseases.

Indexed as

bacterial pathogenshost defenseinfectious diseasesmicroRNAsmitophagy

Identifiers

PMID42852083
PMCPMC13647216

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.